期刊文献+
共找到3篇文章
< 1 >
每页显示 20 50 100
Cardiopulmonary Resuscitation Induced Consciousness—A Case Report from United Arab Emirates
1
作者 Youssef Saleem Abboud Sreya Varanasi 《Open Journal of Emergency Medicine》 2022年第2期80-84,共5页
Cardiopulmonary resuscitation-induced consciousness (CPRIC) is increasingly being reported across the world. High quality cardiopulmonary resuscitation (CPR) may transiently generate sufficient cerebral perfusion to c... Cardiopulmonary resuscitation-induced consciousness (CPRIC) is increasingly being reported across the world. High quality cardiopulmonary resuscitation (CPR) may transiently generate sufficient cerebral perfusion to cause signs of consciousness during CPR which disappears on cessation of CPR. Here we present the case of a 56-year-old male presenting with myocardial infarction that led to cardiac arrest and initiation of CPR during which he showed signs of consciousness. This led to multiple disruptions in delivering high quality CPR. CPR providers are often unaware and inexperienced in managing these patients. However, CPRIC has an association with improved survival. Hence, more research needs to be conducted in this field and guidelines need to be developed to better manage CPRIC. 展开更多
关键词 CONSCIOUSNESS Cardiopulmonary Resuscitation spontaneous movement
下载PDF
A randomized,double-blind,placebo-controlled trial assessing the efficacy and safety of tegaserod in patients from China with chronic constipation 被引量:7
2
作者 San-Ren Lin Mei-Yun Ke +5 位作者 Jin-Yan Luo Yao-Zong Yuan Ji-Yao Wang Shelley diTommaso Verena Walter Jiaqing Huang 《World Journal of Gastroenterology》 SCIE CAS CSCD 2007年第5期732-739,共8页
AIM: To evaluate the efficacy and safety of tegaserod, 6 mg twice daily (b.i.d.), in men and women with chronic constipation (CC) from China. METHODS: This was a multicenter, double-blind, placebo-controlled stu... AIM: To evaluate the efficacy and safety of tegaserod, 6 mg twice daily (b.i.d.), in men and women with chronic constipation (CC) from China. METHODS: This was a multicenter, double-blind, placebo-controlled study. Following a 2-wk treatmentfree baseline period, patients were randomized to receive either tegaserod (6 mg b.i.d.) or placebo (b.i.d.) for 4 wk. An analysis of covariance with repeated measures was used to determine the overall effect of treatment for the primary efficacy variable; the change from baseline in the number of complete spontaneous bowel movements (CSBMs) during the 4-wk treatment period. Secondary efficacy endpoints included other measures of response in terms of CSBMs, and patients' daily and weekly assessment of bowel habits. Safety was also assessed, based on the incidence and severity of adverse events (AEs). RESULTS: A total of 607 patients were randomized to receive either tegaserod (n = 304) or placebo (n = 303). Tegaserod treatment resulted in a rapid and significant increase from baseline in the adjusted mean number of CSBMs per week over wk 1-4 compared with placebo (1.39 vs 0.91, P = 0.0002). A statistically significant difference in favor of tegaserod was also observed for a mean increase ≥ 1 CSBM/wk over wk 1-4 (47.7% vs 35.0%, tegaserod vs placebo, respectively, P = 0.0018) and for the absolute number of≥ 3 CSBMs/wk over wk 1-4 (25.0% vs 14.5%, tegaserod vs placebo, respectively, P = 0.0021). Improvements in other symptoms of CC were also seen in the tegaserod group, including improved stool form and reduced straining. In addition, more patients in the tegaserod group reported satisfactory relief from their constipation symptoms. The frequency and severity of AEs was comparable between tegaserod and placebo groups, with the exception of a greater incidence of diarrhea in patients receiving tegaserod (3.6%) compared with placebo (1.7%). CONCLUSION: Tecjaserod treatment improved multiple symptoms of CC and was associated with a favorable safety profile. 展开更多
关键词 Chronic constipation TEGASEROD China Complete spontaneous bowel movement Placebocontrolled STOOL
下载PDF
Effects of Ning Shen Ling Granule (宁神灵冲剂) and Dehydroepiandrosterone on Cognitive Function in Mice Undergoing Chronic Mild Stress
3
作者 张潇 董毅龙 +3 位作者 杨楠 刘雁勇 高瑞丰 左萍萍 《Chinese Journal of Integrative Medicine》 SCIE CAS 2007年第1期46-49,共4页
Objective: To investigate the changes of spontaneous and cognitive behavior, and cholinergic M receptors in the brain of mice subjected to chronic mild stress (CMS), and to determine the effect of Ning Shen Ling Gr... Objective: To investigate the changes of spontaneous and cognitive behavior, and cholinergic M receptors in the brain of mice subjected to chronic mild stress (CMS), and to determine the effect of Ning Shen Ling Granule (宁神灵冲剂, NSL) and dehydroepiandrosterone (DHEA) on them. Methods:CMS model mice were established by applying stress every day for 3 consecutive weeks with 7 kinds of unforeseeable stress sources, and they were medicated for 1 week beginning at the 3rd week of modeling. The changes in behavior were determined by Morris Water Maze and spontaneous movement test, and M-receptor binding activity in cerebral cortex, hippocampus and hypothalamus were measured by radioactive ligand assay with 3H-QNB. Results: (1) The spontaneous movement in CMS model mice was significantly reduced, with the latency for searching platform in Morris Water Maze obviously prolonged (P〈0.01), and these abnormal changes in behavior were improved in those treated with NSL and DHEA. (2) The binding ability of M-receptor in cerebral cortex and hippocampus of CMS mice was significantly decreased as compared with those in the control group (P〈0.05), but could be restored to the normal level after intervention with NSL or DHEA. Conclusion: The decline of spontaneous movement and spatial learning and memory ability could be induced in animals by chronic mild stress, and that may be related to the low activity of central cholinergic M-receptors. Both NSL and DHEA could effectively alleviate the above-mentioned changes. 展开更多
关键词 chronic mild stressed model Ning Shen Ling Granule DEHYDROEPIANDROSTERONE central cholinergic M-receptor spontaneous movement Morris water maze
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部